04-05-2021 07:15 PM | Source: (Reuters)
India's Panacea Biotec to produce 100 million Sputnik V doses annually - RDIF
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
MOSCOW - Indian biotech firm Panacea Biotec Ltd has agreed to produce 100 million doses of Russia's Sputnik V COVID-19 vaccine annually, the Russian Direct Investment Fund (RDIF), which markets the shot internationally, said on Monday.
RDIF did not say when production would begin.
(Reporting by Vladimir Soldatkin; Writing by Alexander Marrow, ediitng by Emelia Sithole-Matarise)
Latest News
Centre launches portal for nurturing skill developme...
Hyundai, Kia`s Europe sales down 7.5 pc in October
AI-powered voice analysis may revolutionise early di...
Rohit Sharma to join Indian team in Australia on Sunday
Evening Roundup : A Daily Report on Bullion Energy &...
Buy Copper Above 825 SL Below 821 TGT 830/833 - Axis...
Over 9 in 10 Indian leaders anticipate an increase i...
Evening Track : Renewed Geopolitical uncertainty fue...
Mahayuti government is going to be formed: Shiv Sena...
Everything will get clear on the 23rd: BJPs Rahul Na...
